Athersys, Inc. CEO to Present on September 24, 2012 at the Noble Financial Life Sciences Exposition
CLEVELAND, Sept. 18, 2012 (GLOBE NEWSWIRE) -- Gil Van Bokkelen, Chairman and Chief Executive Officer of Athersys, Inc. (Nasdaq:ATHX) will present at the Noble Financial Capital Markets Life Sciences Exposition, a conference focused on therapeutic drug development including regenerative medicine, immunotherapy, and targeted oncology. The presentation is scheduled as follows: